McMillan Shakespeare Ltd (ASX: MMS) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

McMillan Shakespeare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.37 billion
P/E Ratio 18.52
Dividend Yield 7.35%
Shares Outstanding 69.64 million
Earnings per share 0.890
Dividend per share 1.52
Year To Date Return 25.88%
Earnings Yield 5.40%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • McMillan Shakespeare Ltd (ASX: MMS)
    Latest News

    A graph ablaze with fire going up, indicating a fired up and surged share price
    Share Market News

    ASX 200 jumps 2.6%, big 4 banks surge

    The S&P/ASX 200 Index (ASX:XJO) soared 2.6%, the Mesoblast Limited (ASX:MSB) share price jumped 11.6% after last week’s decline.

    Read more »

    Female ASX investor standing with back to camera, reviewing screen of share price charts in front of her
    Share Market News

    Quarterly rebalance: Coles and Fortescue added to ASX 20, Zip joins the ASX 200

    Coles Group Ltd (ASX:COL) and Zip Co Ltd (ASX:Z1P) shares have been added to major indices this morning by S&P/ASX…

    Read more »

    note pad with the words 'what's next' written on it representing uncertainty surrounding mcmillan share price
    Share Market News

    Where to next for the McMillan share price following Wednesday's results?

    The McMillan share price fell more than 6% yesterday following release of the company's FY20 results. Does this make the…

    Read more »

    Cheap Shares

    These ASX stocks might be a better option than Carsales.Com

    Auto sales may have turned a corner but many brokers think Carsales.Com Ltd (ASX: CAR) is too expensive. These ASX…

    Read more »

    Share Market News

    These 5 ASX 200 shares were last week's biggest winners

    The share market was positive last week with the S&P/ASX 200 (ASX: XJO) up 5.3%. We take a look at…

    Read more »

    Share Market News

    3 ASX 200 shares to buy for a Goldilocks-style bounce back

    A Goldilocks-style market recovery bodes well for these 3 ASX 200 shares that remain seriously oversold since the beginning of…

    Read more »

    a woman
    Share Market News

    McMillan Shakespeare shares flat after reporting lower profits

    The McMillan Shakespeare Limited (ASX: MMS) share price ended the day relatively flat following the release of its first-half results.

    Read more »

    a woman
    Share Fallers

    Why these 10 ASX 200 shares are down more than 10% this month

    The ASX 200 has had an up and down start to December, but these 10 shares have plummeted 10% or…

    Read more »

    a woman
    Share Market News

    ALL ORDINARIES finishes higher Monday: 8 ASX shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished higher on Monday, here are 8 ASX shares you missed.

    Read more »

    a woman
    Share Fallers

    Why a2 Milk, Elixinol Global, Estia Health, & McMillan Shakespeare are dropping lower

    The A2 Milk Company Ltd (ASX:A2M) share price and the Elixinol Global Ltd (ASX:EXL) share price are two of four…

    Read more »

    a woman
    Share Market News

    ASX 200 lunch update: A2 Milk & NIB lower, Western Areas higher

    A2 Milk Company Ltd (ASX:A2M), McMillan Shakespeare Limited (ASX:MMS), and NIB Holdings Limited (ASX:NHF) shares are making a splash on…

    Read more »

    a woman
    Share Market News

    Why the McMillan Shakespeare share price is crashing 13% lower

    Here's why the McMillan Shakespeare Limited (ASX:MMS) share price is crashing lower on Monday...

    Read more »

    Frequently Asked Questions

    Yes, McMillan Shakespeare historically pays two fully franked dividends a year.

    McMillan Shakespeare generally pays its shareholder dividends in March and September.

    McMillan Shakespeare Ltd list on the ASX on 2 July 2018.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    07 Mar 2024 $0.7600 100.00% Interim 22 Mar 2024
    07 Sep 2023 $0.6600 100.00% Final 22 Sep 2023
    09 Mar 2023 $0.5800 100.00% Final 24 Mar 2023
    26 Oct 2022 $0.7400 100.00% Final 10 Nov 2022
    10 Mar 2022 $0.3400 100.00% Interim 25 Mar 2022
    09 Sep 2021 $0.3110 100.00% Final 24 Sep 2021
    11 Mar 2021 $0.3020 100.00% Interim 26 Mar 2021
    05 Mar 2020 $0.3400 100.00% Interim 20 Mar 2020
    28 Aug 2019 $0.4000 100.00% Final 11 Sep 2019
    07 Mar 2019 $0.3400 100.00% Interim 22 Mar 2019
    13 Sep 2018 $0.4000 100.00% Final 28 Sep 2018
    15 Mar 2018 $0.3300 100.00% Interim 29 Mar 2018
    28 Sep 2017 $0.0000 100.00% Final 13 Oct 2017
    30 Mar 2017 $0.3100 100.00% Interim 13 Apr 2017
    29 Sep 2016 $0.3400 100.00% Final 14 Oct 2016
    31 Mar 2016 $0.2900 100.00% Interim 15 Apr 2016
    16 Sep 2010 $0.1400 100.00% Final 15 Oct 2010
    08 Mar 2006 $0.0250 100.00% Interim 29 Mar 2006
    18 Aug 2005 $0.0240 100.00% Final 16 Sep 2005

    MMS ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About McMillan Shakespeare Ltd

    McMillan Shakespeare Ltd (ASX: MMS) is an employee benefits provider. Its services include salary packaging, novated leasing, disability plan management and support coordination, asset management, and related financial products and services.

    The company's asset management businesses provide motor vehicle leasing and fleet management services, as well as fleet and consumer financing.

    McMillan Shakespeare consists of more than 20 subsidiaries, the majority incorporated in Australia but also in New Zealand and the United Kingdom.

    MMS Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    28 Mar 2024 $19.63 $0.30 1.55% 247,466 $19.28 $19.63 $19.14
    27 Mar 2024 $19.33 $0.51 2.71% 427,852 $19.46 $19.49 $18.91
    26 Mar 2024 $18.82 $-0.43 -2.23% 408,006 $19.30 $19.31 $18.53
    25 Mar 2024 $19.25 $-0.27 -1.38% 268,747 $19.66 $19.69 $19.03
    22 Mar 2024 $19.52 $-0.27 -1.36% 162,295 $19.54 $19.92 $19.52
    21 Mar 2024 $19.79 $0.43 2.22% 256,361 $19.60 $19.93 $19.60
    20 Mar 2024 $19.36 $-0.14 -0.72% 135,541 $19.41 $19.76 $19.35
    19 Mar 2024 $19.50 $-0.27 -1.37% 245,181 $19.78 $20.10 $19.50
    18 Mar 2024 $19.77 $-0.13 -0.65% 215,562 $19.91 $20.07 $19.50
    15 Mar 2024 $19.90 $0.06 0.30% 339,792 $19.89 $20.00 $19.60
    14 Mar 2024 $19.84 $-0.65 -3.17% 233,485 $20.44 $20.59 $19.84
    13 Mar 2024 $20.49 $0.05 0.24% 137,507 $20.55 $20.75 $20.44
    12 Mar 2024 $20.44 $-0.31 -1.49% 107,392 $20.89 $20.89 $20.34
    11 Mar 2024 $20.75 $-0.03 -0.14% 195,014 $20.53 $20.93 $20.44
    08 Mar 2024 $20.78 $0.13 0.63% 296,604 $20.71 $21.09 $20.57
    07 Mar 2024 $20.65 $-0.26 -1.24% 262,522 $19.95 $20.65 $19.78
    06 Mar 2024 $20.91 $-0.73 -3.37% 286,620 $21.69 $21.69 $20.91
    05 Mar 2024 $21.64 $0.08 0.37% 292,745 $21.60 $21.88 $21.52
    04 Mar 2024 $21.56 $-0.32 -1.46% 309,516 $21.90 $22.10 $21.50
    01 Mar 2024 $21.88 $-0.02 -0.09% 188,436 $22.00 $22.07 $21.74
    29 Feb 2024 $21.90 $0.04 0.18% 357,732 $21.78 $22.05 $21.70
    28 Feb 2024 $21.86 $0.08 0.37% 263,629 $21.80 $21.94 $21.54

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    17 Nov 2023 Robert (Rob) De Luca Issued 58,970 $1,043,179
    Issue of securities. 162,498 Performance Rights
    24 Aug 2023 Kathryn Parsons Buy 500 $9,650
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Bruce John Akhurst Non-Executive Director Apr 2021
    Mr Akhurst is currently the Chairman of Tabcorp Holdings Limited and a member of the Audit Committee, Technology Committee, Nomination Committee, People and Remuneration Committee and Interim Chair of the Risk, Compliance and Sustainability Committee. Mr Akhurst is also Chair of the Peter McCallum Cancer Foundation and Council Member of RMIT University chairing the Infrastructure and Information Technology Committee.
    Mr John G Bennetts Non-Executive Director Dec 2003
    Mr Bennetts is an experienced investor and has been the founder and director of a number of Australian companies. He owns businesses in varied industries including technology and finance. Mr Bennetts is a Non-Executive Director of Sacred Heart Mission. He was a founder of Cellestis Limited and private equity investment firm, Mooroolbark Investments Pty Limited (M-Group). He has also provided corporate advisory services to a range of companies in Australia and Asia.
    Mr Ross Chessari Non-Executive Director Dec 2003
    Mr Chessari is a founder and director of the investment manager, SciVentures Investments Pty Limited (SciVentures). Prior to founding SciVentures, Mr Chessari was the Managing Director of ANZ Asset Management and the General Manager of ANZ Trustees.
    Ms Helen Kurincic Non-Executive DirectorNon-Executive Chairman Sep 2018
    Ms Kurincic is Non-Executive Chair of Integral Diagnostics Limited, Non-Executive Director of Estia Health Limited, HBF Health Limited and the Victorian Clinical Genetics Service. Formerly, Ms Kurincic was the Chief Operating Officer and Director of Genesis Care from its inception, creating and developing the first and radiation oncology and cardiology business across Australia. She has also formerly held Board roles across the publicly listed, private, not-for-profit and government sectors as well as being the former CEO of Benetas and Heart Care Victoria. Ms Kurincic is a Fellow of the Australian Institute of Company Directors and Governance Institute of Australia. She has also completed the Cambridge Institute for Sustainability Leadership NED Programme.
    Ms Arlene May Tansey Non-Executive Director Nov 2022
    Ms Tansey is a Non-Executive Director of TPG Telecom, Aristocrat Leisure Limited, Wisetech Global, Lend Lease Real Estate Investments Limited, the Australian Institute of Company Directors (NSW Division Council) and the Australian National Maritime Museum. Arlene is also a member of the Board of Advice of the University of Sydney Business School. Before becoming a non-executive Director, Arlene worked in commercial and investment banking in Australia (ANZ Banking Group and Macquarie Bank) and in investment banking and law in the United States.
    Mr Robert (Rob) De Luca Chief Executive OfficerManaging Director May 2022
    Mr De Luca joined MMS in May 2022 and has over 20 years experience in Financial Services, Wealth Management, Disability and Healthcare, including roles as Managing Director of Bankwest, CEO of the National Disability Insurance Agency (NDIA) and most recently as CEO of Zenitas Healthcare.
    Ms Kathryn Maree Parsons Non-Executive Director May 2020
    Ms Parsons is currently a Non-Executive Director of Tassal Group Limited and a NonExecutive Director of Shape Australia Corporation Limited. Formerly, Ms Parsons was an audit partner at Ernst & Young where she spent time as a partner in the firm's US, UK and Australian practices. In addition to her audit client responsibilities she was part of the firm's Oceania Assurance Leadership team as the Professional Practice Director with responsibility for assurance quality and risk management in the region.

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Aust) Ltd 17,717,211 25.44%
    JP Morgan Nominees Australia Limited 9,889,906 14.20%
    Citicorp Nominees Limited 8,878,618 12.75%
    Chessari Holdings Pty Limited 6,050,941 8.69%
    AP Group Pty Limited 3,976,229 5.71%
    National Nominees Limited 3,408,305 4.89%
    Asia Pac Technology Pty Ltd 3,068,025 4.41%
    UBS Nominees Pty Limited 1,971,968 2.83%
    Ann Leslie Ryan 1,008,418 1.45%
    BNP Paribas Nom Pty Limited <DRP> 756,878 1.09%
    NewEconomy com AU Nominees Pty Limited 327,205 0.47%
    MOHL Invest Pty Ltd <MOHL Super Fund A/c> 310,000 0.45%
    Citicorp Nominees Pty Ltd <Colonial First State Inv A/c> 237,391 0.34%
    Warbont Nominees Pty Ltd <Unpaid Entrepot A/c> 224,539 0.32%
    BNP Paribas Noms Pty Ltd <Global markets DRP> 174,569 0.25%
    AFICO Pty Ltd 130,000 0.19%
    Mod Enterprises Pty Ltd 129,619 0.19%
    WAL Assets Pty Ltd <The LA Wilson Property A/c> 114,795 0.16%
    Birdseye No. Management Pty Ltd <Birdseye Super No. Fund A/c> 110,000 0.16%
    BNP Paribas Nominees Pty Ltd Hub4 Custodial Serv Ltd <DRP A/c> 99,864 0.14%

    Profile

    since

    Note